Brandywine Global Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $77.6M | Sell |
|
|||||
2025
Q1 | $79M | Sell |
|
|||||
2024
Q4 | $68.4M | Buy |
|
|||||
2024
Q3 | $14.6M | Buy |
|
|||||
2024
Q2 | – | Sell |
|
|||||
2024
Q1 | $46.8M | Sell |
|
|||||
2023
Q4 | $126M | Buy |
|
|||||
2023
Q3 | $115M | Buy |
|
|||||
2023
Q2 | $88.4M | Buy |
|
|||||
2023
Q1 | $65.5M | Buy |
|
|||||
2022
Q4 | $65M | Sell |
|
|||||
2022
Q3 | $50M | Sell |
|
|||||
2022
Q2 | $50.9M | Sell |
|
|||||
2022
Q1 | $51.9M | Sell |
|
|||||
2021
Q4 | $66.5M | Buy |
|
|||||
2021
Q3 | $61.1M | Buy |
|
|||||
2020
Q4 | – | Sell |
|
|||||
2020
Q3 | $67.1M | Sell |
|
|||||
2020
Q2 | $84.6M | Sell |
|
|||||
2020
Q1 | $99.1M | Sell |
|
|||||
2019
Q4 | $114M | Buy |
|
|||||
2019
Q3 | $107M | Sell |
|
|||||
2019
Q2 | $122M | Sell |
|
|||||
2019
Q1 | $119M | Buy |
|
|||||
2018
Q4 | $109M | Sell |
|
|||||
2018
Q3 | $145M | Sell |
|
|||||
2018
Q2 | $137M | Sell |
|
|||||
2018
Q1 | $148M | Buy |
|
|||||
2017
Q4 | $135M | Buy |
|
|||||
2017
Q3 | $98.5M | Buy |
|
|||||
2017
Q2 | $54.6M | Sell |
|
|||||
2017
Q1 | $75.8M | Sell |
|
|||||
2016
Q4 | $80.7M | Buy |
|
|||||
2016
Q3 | $83.8M | Sell |
|
|||||
2016
Q2 | $172M | Buy |
|
|||||
2016
Q1 | $123M | Sell |
|
|||||
2015
Q4 | $137M | Buy |
|
|||||
2015
Q3 | $127M | Buy |
|
|||||
2015
Q2 | $107M | Buy |
|
|||||
2015
Q1 | $82.5M | Buy |
|
|||||
2014
Q4 | $32.8M | Buy |
|